Hostname: page-component-89b8bd64d-z2ts4 Total loading time: 0 Render date: 2026-05-11T07:37:01.775Z Has data issue: false hasContentIssue false

Artificial intelligence for early detection of renal cancer in computed tomography: A review

Published online by Cambridge University Press:  11 November 2022

William C. McGough*
Affiliation:
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK Department of Oncology, University of Cambridge, Cambridge, UK
Lorena E. Sanchez
Affiliation:
Department of Radiology, University of Cambridge, Cambridge, UK Cancer Research UK Cambridge Centre, Cambridge, UK
Cathal McCague
Affiliation:
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK Department of Radiology, University of Cambridge, Cambridge, UK Cancer Research UK Cambridge Centre, Cambridge, UK
Grant D. Stewart
Affiliation:
Cancer Research UK Cambridge Centre, Cambridge, UK Department of Surgery, University of Cambridge, Cambridge, UK
Carola-Bibiane Schönlieb
Affiliation:
Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK
Evis Sala
Affiliation:
Department of Radiology, University of Cambridge, Cambridge, UK Cancer Research UK Cambridge Centre, Cambridge, UK
Mireia Crispin-Ortuzar
Affiliation:
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK Department of Oncology, University of Cambridge, Cambridge, UK
*
Author for correspondence: William C. McGough, Email: wcm23@cam.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Renal cancer is responsible for over 100,000 yearly deaths and is principally discovered in computed tomography (CT) scans of the abdomen. CT screening would likely increase the rate of early renal cancer detection, and improve general survival rates, but it is expected to have a prohibitively high financial cost. Given recent advances in artificial intelligence (AI), it may be possible to reduce the cost of CT analysis and enable CT screening by automating the radiological tasks that constitute the early renal cancer detection pipeline. This review seeks to facilitate further interdisciplinary research in early renal cancer detection by summarising our current knowledge across AI, radiology, and oncology and suggesting useful directions for future novel work. Initially, this review discusses existing approaches in automated renal cancer diagnosis, and methods across broader AI research, to summarise the existing state of AI cancer analysis. Then, this review matches these methods to the unique constraints of early renal cancer detection and proposes promising directions for future research that may enable AI-based early renal cancer detection via CT screening. The primary targets of this review are clinicians with an interest in AI and data scientists with an interest in the early detection of cancer.

Information

Type
Review
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press
Figure 0

Table 1. The current state of satisfaction of Wilson–Junger criteria for AI RC screening in LDCT

Figure 1

Figure 1. A segmented CECT axial slice, depicting the segmented kidneys (blue) and tumour(red). CT data taken from KiTS19, case 49.

Figure 2

Figure 2. An example ROC curve for an arbitrary classifier, displaying the trade-off between sensitivity and specificity in an arbitrary classification task. The further the curve is from the x-axis, and the closer it is to the y-axis, the higher the classifier’s holistic accuracy and AUC. In the shown ROC curve, AUC is 0.699.

Figure 3

Figure 3. The performance distribution of the top-7 algorithms in KiTS19 and KiTS21, with respect to mass segmentation DSC. Due to the labelling differences between KiTS19 and KiTS21, all masses in KiTS19 are labelled as ‘Tumour’, whereas masses in KiTS21 are labelled as either ‘Tumour’ or ‘Cyst’.

Supplementary material: File

McGough et al. supplementary material

McGough et al. supplementary material

Download McGough et al. supplementary material(File)
File 30.1 KB

Author comment: The environmental impact of data-driven precision medicine initiatives — R0/PR1

Comments

Dear Mrs Vance,

As we recently discussed via email, we are happy to submit the invited review entitled "New Approaches To the Early Detection of Renal Cancer with Artificial Intelligence in Computed Tomography" for publication in your journal, Cambridge Prisms: Precision Medicine.

The attached review is the result of an interdisciplinary collaboration between the University of Cambridge's Departments of Oncology, Radiology, and Applied Mathematics and Theoretical Physics, and it attempts to lay the scholarly foundation for the development of AI in renal cancer early detection. The development of AI tools that can automate CT analysis is thought to be vital for reducing the cost of renal cancer screening, and the success of such AI development is likely to play a decisive role in enabling renal cancer screening via CT.

We hope this review will facilitate further interdisciplinary research between radiologists, oncologists, and radiologists in the early detection of renal cancer. Initially, this review discusses existing approaches in automated renal cancer diagnosis, and methods across broader AI research, to summarise the existing state of AI in cancer analysis. We then match these methods to the unique constraints of early renal cancer detection and propose promising directions for future research that may enable AI-based early renal cancer detection via CT screening.

The primary targets of this review are clinicians with an interest in AI and data scientists with an interest in the early detection of cancer.

Thank you for your consideration, and we look forward to hearing back from you.

Yours Sincerely,

William McGough, for the authors

Review: The environmental impact of data-driven precision medicine initiatives — R0/PR2

Conflict of interest statement

Reviewer declares none.

Comments

Comments to Author: This review deals with advances in AI for radiological early detection of renal cell carcinoma (RCC). The focus is on technical aspects and the developments therein, whereas the route to implementation and the role it can have in screening is superficially dealt with. The title is not fully in line with the scope.

This review is interesting mainly for readers who are interested in technical aspects of the use of AI in radiology

Remarks:

- although this is not a systematic review, still some indication on the approach to find and select articles are needed

- the authors describe that many of the 10 Wilson-Junger criteria are met, yet give examples that are not met. I am doubtful that CT for early RCC is really close to implementation; a table might be helpful

- it is stated that for screening te procedure needs to quick, with rapid reporting: for screening this is less important for clinical questions; in fact some actual screening methods like for colorectal cancer and cervical cancer are not that quick

- the term classification is used in two different situations: radiological and pathological. This leads to confusion: in the one case it is tissue/tumor separation in the other it is the categorization into tumortype

- some examples of application of AI in clinical practice are given, including in pathology. Although there are several articles, there is very little implementation in pathology practice, in fact probably only in the field of lymph node evaluation for metastasis, which is not mentioned in the review. Furthermore, there is literature on the use of AI in radiology in lung and breast cancer screening that gets very little attention

Recommendation: The environmental impact of data-driven precision medicine initiatives — R0/PR3

Comments

Comments to Author: This manuscript gives an extensive and technical overview of repurposing existing AI approaches for RCC early detection, ending with recommendations to improve both segmentation and classification approaches to enable early RCC detection.

This is a well-written review of the literature and I believe will be well received by the community.

A few suggestions:

1) I suggest combining subsections 3.3 and 3.4 to be consistent with section 2.

2) I suggest including a table summarising each reference referred to in sections 3 and 4 would support the reader in navigating between referrals to the references in the Discussion with the main body of the text

3) I wonder if the title should be something like: 'ADVANCING EARLY DETECTION OF RENAL CANCER WITH ARTIFICIAL INTELLIGENCE IN COMPUTED TOMOGRAPHY'. As not all approaches in the paper are 'new'?

4) The abstract of the article and impact statement must be given in the article before the introduction.

In general, the paper was clear and adds to the knowledge in this field - I hope to see the recommendations made in this article taken forward.

Decision: The environmental impact of data-driven precision medicine initiatives — R0/PR4

Comments

No accompanying comment.

Author comment: The environmental impact of data-driven precision medicine initiatives — R1/PR5

Comments

No accompanying comment.

Review: The environmental impact of data-driven precision medicine initiatives — R1/PR6

Conflict of interest statement

Reviewer declares none.

Comments

Comments to Author: This review has improved substantially

Recommendation: The environmental impact of data-driven precision medicine initiatives — R1/PR7

Comments

No accompanying comment.

Decision: The environmental impact of data-driven precision medicine initiatives — R1/PR8

Comments

No accompanying comment.